Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis Theme



Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies

The No.1 Research Site For Therapeutic Peptides


Humanin 5mg


Humanin 5mg

Humanin is a small, bioactive peptide consisting of 24 amino acids. It was initially discovered in 2001 during a study on Alzheimer’s disease. Humanin is known for its neuroprotective, anti-apoptotic, and cytoprotective properties, and it has been investigated for its potential role in a variety of diseases, including neurodegenerative disorders, cardiovascular diseases, and age-related conditions.

Previous and ongoing research on Humanin has focused on several key areas:

  1. Neuroprotection: Humanin has been studied for its potential to protect neurons from cell death and damage, particularly in the context of Alzheimer’s disease and other neurodegenerative conditions.
  2. Cardiovascular protection: Humanin has demonstrated cardioprotective properties in some studies, suggesting its potential to protect the heart from ischemia-reperfusion injury, atherosclerosis, and other cardiovascular diseases.
  3. Metabolic regulation: Research has also focused on Humanin’s potential role in regulating metabolism, insulin sensitivity, and glucose homeostasis, which could have implications for diabetes and other metabolic disorders.
  4. Anti-aging and longevity: Humanin’s cytoprotective and anti-apoptotic effects have generated interest in its potential role in promoting healthy aging and longevity.

Current research on Humanin is focused on further understanding its mechanisms of action, optimizing its therapeutic applications, and investigating its safety and efficacy in various populations and medical conditions. Some recent research papers related to Humanin include:

  1. Lee, C., Wan, J., & Miyazaki, B. (2020). “Humanin: Functional Interfaces with IGF-I.” Growth Hormone & IGF Research, 52, 101317. [This review paper discusses the functional interfaces between Humanin and insulin-like growth factor 1 (IGF-I), with potential implications for neurodegenerative diseases, metabolic disorders, and aging.]
  2. Matsuoka, M. (2019). “Humanin: A Mitochondrial-Derived Peptide for Treating Alzheimer’s Disease.” Current Alzheimer Research, 16(9), 818-830. [This review paper provides an overview of the neuroprotective effects of Humanin and its potential as a therapeutic agent for Alzheimer’s disease.]
  3. Hashimoto, Y., & Niikura, T. (2016). “Humanin: A Multifunctional Peptide Encoded by a Small Open Reading Frame.” In Mini Hotspot in Genetics and Molecular Biology of Complex Diseases (pp. 45-68). Springer, Singapore. [This book chapter provides an overview of the various biological functions of Humanin, including its neuroprotective, cardioprotective, and metabolic effects.]

Peptides are the future of medicine. They are potent, tissue specific and effective at treating a variety of conditions with little to no side effects.

Dean Henry
Function Medicine Coach and Health Optimiser

Peptides are the next frontier in biohacking and performance enhancement. They can boost muscle growth, accelerate fat loss, improve sleep, increase energy and focus, and promote overall health and longevity.

Ben Greenfield
Biohacker and Health Expert

Peptides are tiny chains of amino acids that have powerful effects on the brain and body. They can improve memory, focus, and mood, and have anti-anxiety and anti-depressant effects.

Dr. Andrew Huberman, PhD
Professor of Neurobiology at Stanford University